|
1
|
Ballhause TM, Soldati R and Mertens PR:
Sources of myofibroblasts in kidney fibrosis: All answers are
correct, however to different extent! Int Urol Nephrol. 46:659–664.
2014. View Article : Google Scholar
|
|
2
|
Liu Y: New insights into
epithelial-mesenchymal transition in kidney fibrosis. J Am Soc
Nephrol. 21:212–222. 2010. View Article : Google Scholar
|
|
3
|
Cantrell DA: Phosphoinositide 3-kinase
signalling pathways. J Cell Sci. 114:1439–1445. 2001.PubMed/NCBI
|
|
4
|
Ye B, Jiang LL, Xu HT, Zhou DW and Li ZS:
Expression of PI3K/AKT pathway in gastric cancer and its blockade
suppresses tumor growth and metastasis. Int J Immunopathol
Pharmacol. 25:627–636. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hassan B, Akcakanat A, Holder AM and
Meric-Bernstam F: Targeting the PI3-kinase/Akt/mTOR signaling
pathway. Surg Oncol Clin N Am. 22:641–664. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang T, Liang Y, Lin Q, Liu J, Luo F, Li
X, Zhou H, Zhuang S and Zhang H: miR-29 mediates TGFβ1-induced
extracellular matrix synthesis through activation of PI3K-AKT
pathway in human lung fibroblasts. J Cell Biochem. 114:1336–1342.
2013. View Article : Google Scholar
|
|
7
|
Wang J, Chu ES, Chen HY, Man K, Go MY,
Huang XR, Lan HY, Sung JJ and Yu J: microRNA-29b prevents liver
fibrosis by attenuating hepatic stellate cell activation and
inducing apoptosis through targeting PI3K/AKT pathway. Oncotarget.
6:7325–7338. 2015.
|
|
8
|
Qin J, Xie YY, Huang L, Yuan QJ, Mei WJ,
Yuan XN, Hu GY, Cheng GJ, Tao LJ and Peng ZZ: Fluorofenidone
inhibits nicotinamide adenine dinucleotide phosphate oxidase via
PI3K/Akt pathway in the pathogenesis of renal interstitial
fibrosis. Nephrology (Carlton). 18:690–699. 2013.
|
|
9
|
Burns WC, Velkoska E, Dean R, Burrell LM
and Thomas MC: Angiotensin II mediates epithelial-to-mesenchymal
transformation in tubular cells by ANG 1-7/MAS-1-dependent
pathways. Am J Physiol Renal Physiol. 299:F585–F593. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan B, Guo Q, Fu FJ, Wang Z, Yin Z, Wei YB
and Yang JR: The role of miR-29b in cancer: Regulation, function,
and signaling. Onco Targets Ther. 8:539–548. 2015.PubMed/NCBI
|
|
11
|
Bayoumi AS, Sayed A, Broskova Z, Teoh JP,
Wilson J, Su H, Tang YL and Kim IM: Crosstalk between long
noncoding RNAs and microRNAs in health and disease. Int J Mol Sci.
17:E3562016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
van Rooij E, Sutherland LB, Thatcher JE,
DiMaio JM, Naseem RH, Marshall WS, Hill JA and Olson EN:
Dysregulation of microRNAs after myocardial infarction reveals a
role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA.
105:13027–13032. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cushing L, Kuang PP, Qian J, Shao F, Wu J,
Little F, Thannickal VJ, Cardoso WV and Lü J: miR-29 is a major
regulator of genes associated with pulmonary fibrosis. Am J Respir
Cell Mol Biol. 45:287–294. 2011. View Article : Google Scholar :
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
15
|
Pan J, Zhang J, Zhang X, Zhou X, Lu S,
Huang X, Shao J, Lou G, Yang D and Geng YJ: Role of microRNA-29b in
angiotensin II-induced epithelial-mesenchymal transition in renal
tubular epithelial cells. Int J Mol Med. 34:1381–1387. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Okada H, Ban S, Nagao S, Takahashi H,
Suzuki H and Neilson EG: Progressive renal fibrosis in murine
polycystic kidney disease: An immunohistochemical observation.
Kidney Int. 58:587–597. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Djudjaj S, Papasotiriou M, Bülow RD,
Wagnerova A, Lindenmeyer MT, Cohen CD, Strnad P, Goumenos DS,
Floege J and Boor P: Keratins are novel markers of renal epithelial
cell injury. Kidney Int. 89:792–808. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen J, Chen JK and Harris RC: Angiotensin
II induces epithelial-to-mesenchymal transition in renal epithelial
cells through reactive oxygen species/Src/caveolin-mediated
activation of an epidermal growth factor receptor-extracellular
signal-regulated kinase signaling pathway. Mol Cell Biol.
32:981–991. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Burns WC and Thomas MC: Angiotensin II and
its role in tubular epithelial to mesenchymal transition associated
with chronic kidney disease. Cells Tissues Organs. 193:74–84. 2011.
View Article : Google Scholar
|
|
20
|
Yano N, Suzuki D, Endoh M, Zhao TC,
Padbury JF and Tseng YT: A novel phosphoinositide
3-kinase-dependent pathway for angiotensin II/AT-1
receptor-mediated induction of collagen synthesis in MES-13
mesangial cells. J Biol Chem. 282:18819–18830. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Macconi D, Remuzzi G and Benigni A: Key
fibrogenic mediators: Old players. Renin-angiotensin system. Kidney
Int Suppl (2011). 4:58–64. 2014. View Article : Google Scholar
|
|
22
|
Zavadil J and Böttinger EP: TGF-beta and
epithelial-to-mesenchymal transitions. Oncogene. 24:5764–5774.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang F, Huang XR, Chung AC, Hou CC, Lai KN
and Lan HY: Essential role for Smad3 in angiotensin II-induced
tubular epithelial-mesenchymal transition. J Pathol. 221:390–401.
2010.PubMed/NCBI
|
|
24
|
Meng XM, Tang PM, Li J and Lan HY:
TGF-β/Smad signaling in renal fibrosis. Front Physiol. 6:822015.
View Article : Google Scholar
|
|
25
|
Rodríguez-Vita J, Sánchez-López E, Esteban
V, Rupérez M, Egido J and Ruiz-Ortega M: Angiotensin II activates
the Smad pathway in vascular smooth muscle cells by a transforming
growth factor-beta-independent mechanism. Circulation.
111:2509–2517. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Denby L and Baker AH: Targeting non-coding
RNA for the therapy of renal disease. Curr Opin Pharmacol.
27:70–77. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Simpson K, Wonnacott A, Fraser DJ and
Bowen T: MicroRNAs in diabetic nephropathy: From biomarkers to
therapy. Curr Diab Rep. 16:352016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gomez IG, Nakagawa N and Duffield JS:
MicroRNAs as novel therapeutic targets to treat kidney injury and
fibrosis. Am J Physiol Renal Physiol. 310:F931–F944. PubMed/NCBI
|
